Pneumococci: immunology of the innate host response
- PMID: 20646240
- PMCID: PMC2956737
- DOI: 10.1111/j.1440-1843.2010.01814.x
Pneumococci: immunology of the innate host response
Abstract
Despite the development of vaccines and antibiotics, Streptococcus pneumoniae (the pneumococcus) continues to be a major cause of human morbidity and mortality throughout the world. In recent years our understanding of how the host innate immune system recognizes and responds to pneumococcal infection has advanced significantly. Herein, we highlight some of the key features of the innate response to the pneumococcus.
© 2010 The Authors; Respirology © 2010 Asian Pacific Society of Respirology.
Conflict of interest statement
Conflict of interest statement: C. J. O. has received funding for research unrelated to this review from Novartis Pharmaceuticals.
Similar articles
-
The innate immune response to pneumococcal lung infection: the untold story.Trends Immunol. 2004 Mar;25(3):143-9. doi: 10.1016/j.it.2003.12.006. Trends Immunol. 2004. PMID: 15036042 Review. No abstract available.
-
Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.Microbes Infect. 2020 Sep;22(8):312-321. doi: 10.1016/j.micinf.2019.12.005. Epub 2020 Jan 17. Microbes Infect. 2020. PMID: 31958572
-
Innate immunity and the pneumococcus.Microbiology (Reading). 2006 Feb;152(Pt 2):285-293. doi: 10.1099/mic.0.28551-0. Microbiology (Reading). 2006. PMID: 16436416 Review.
-
Nucleic Acid-Sensing Toll-Like Receptors Play a Dominant Role in Innate Immune Recognition of Pneumococci.mBio. 2020 Mar 24;11(2):e00415-20. doi: 10.1128/mBio.00415-20. mBio. 2020. PMID: 32209688 Free PMC article.
-
[Immunological mechanism in the pathogenesis of pneumococcal pneumonia and in the effectiveness of anti-pneumococcal vaccines].Nihon Naika Gakkai Zasshi. 2015 Nov 10;104(11):2307-13. doi: 10.2169/naika.104.2307. Nihon Naika Gakkai Zasshi. 2015. PMID: 28520388 Japanese. No abstract available.
Cited by
-
Cardiotoxicity during invasive pneumococcal disease.Am J Respir Crit Care Med. 2015 Apr 1;191(7):739-45. doi: 10.1164/rccm.201411-1951PP. Am J Respir Crit Care Med. 2015. PMID: 25629643 Free PMC article. Review.
-
Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.Clin Chest Med. 2017 Jun;38(2):263-277. doi: 10.1016/j.ccm.2016.12.005. Epub 2017 Mar 1. Clin Chest Med. 2017. PMID: 28477638 Free PMC article. Review.
-
The pneumococcal polysaccharide capsule and pneumolysin differentially affect CXCL8 and IL-6 release from cells of the upper and lower respiratory tract.PLoS One. 2014 Mar 24;9(3):e92355. doi: 10.1371/journal.pone.0092355. eCollection 2014. PLoS One. 2014. PMID: 24664110 Free PMC article.
-
Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children.Front Pediatr. 2019 Jun 25;7:233. doi: 10.3389/fped.2019.00233. eCollection 2019. Front Pediatr. 2019. PMID: 31294001 Free PMC article. Review.
-
Inhibitors of Streptococcus pneumoniae surface endonuclease EndA discovered by high-throughput screening using a PicoGreen fluorescence assay.J Biomol Screen. 2013 Mar;18(3):247-57. doi: 10.1177/1087057112461153. Epub 2012 Sep 26. J Biomol Screen. 2013. PMID: 23015019 Free PMC article.
References
-
- O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. - PubMed
-
- Lynch JP, Zhanel GG. Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention. Seminars in Respiratory and Critical Care Medicine. 2009;30:189–209. - PubMed
-
- Malley R. Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J Mol Med. 2010;88:135–42. - PubMed
-
- Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:16969–74. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical